Homology Medicines Announces Publication in Life Science Leader

BEDFORD, Mass., Janaury 26, 2021 – Homology Medicine’s President and Chief Executive Officer, Arthur Tzianabos, Ph.D., wrote an article for Life Science Leader’s CEO Corner, in which he discusses his perspective on why he believes the Massachusetts life sciences industry “will continue to be a dominant force in the sector, particularly in rare genetic disease drug development.”

Theresa McNeely
Chief Communications Officer
and Patient Advocate
tmcneely@homologymedicines.com
781-301-7277

Media Contact:
Cara Mayfield
Senior Director, Patient Advocacy
and Corporate Communications
cmayfield@homologymedicines.com
781-691-3510

< BACK